May-16-22 09:40AM |
Is Galapagos (GLPG) Outperforming Other Medical Stocks This Year?Zacks Investment Research |
May-11-22 09:47AM |
Perrigo (PRGO) Q1 Earnings Miss, Margins Hurt by Higher CostsZacks Investment Research |
May-09-22 03:30AM |
RBC Expects Business Development To Unlock This Pharma Stock's Balance Sheet ValueBenzinga |
May-06-22 04:01AM |
Galapagos creëert nieuwe inschrijvingsrechtenplannen GlobeNewswire Inc. |
May-05-22 08:43AM |
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder StudyBenzinga |
Apr-28-22 09:40AM |
Has Galapagos (GLPG) Outpaced Other Medical Stocks This Year?Zacks Investment Research |
Apr-04-22 09:10AM |
Strength Seen in Galapagos NV (GLPG): Can Its 5% Jump Turn into More Strength?Zacks Investment Research |
Mar-28-22 02:01AM |
Jyseleca® goedgekeurd voor colitis ulcerosa in JapanGlobeNewswire Inc. |
Mar-24-22 04:17AM |
Correction: Galapagos publiceert 2021 jaarverslag en kondigt buitengewone en jaarlijkse aandeelhoudersvergaderingen aanGlobeNewswire Inc. |
04:01AM |
Galapagos publiceert 2021 jaarverslag en kondigt buitengewone en jaarlijkse aandeelhoudersvergaderingen aanGlobeNewswire Inc. |
Mar-18-22 05:01AM |
Galapagos increases share capital through subscription right exercisesGlobeNewswire Inc. |
Feb-28-22 12:33PM |
Tracking David Einhorn's Greenlight Capital Portfolio - Q4 2021 UpdateSeeking Alpha |
Feb-24-22 04:01AM |
Galapagos 2021 results set stage for future growthGlobeNewswire Inc. |
Feb-17-22 08:00AM |
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For AgiosBenzinga |
Feb-13-22 08:32AM |
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And MoreBenzinga |
Feb-03-22 04:01AM |
Galapagos receives transparency notification from EcoR1 CapitalGlobeNewswire Inc. |
Feb-02-22 04:01AM |
Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s and Colitis Organization (ECCO) annual congress GlobeNewswire Inc. |
Jan-27-22 07:57AM |
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster StudyBenzinga |
Jan-26-22 04:40AM |
Galapagos creëert nieuw inschrijvingsrechtenplanGlobeNewswire Inc. |
04:01AM |
Galapagos benoemt Paul Stoffels tot Chief Executive OfficerGlobeNewswire Inc. |
Jan-19-22 07:40AM |
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive DataBenzinga |
Jan-18-22 04:01AM |
JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN GlobeNewswire Inc. |
Jan-13-22 04:01AM |
Galapagos creëert nieuw inschrijvingsrechtenplanGlobeNewswire Inc. |
Jan-06-22 09:30AM |
Galapagos to present at 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire Inc. |
Dec-03-21 04:01AM |
Galapagos increases share capital through subscription right exercisesGlobeNewswire Inc. |
Nov-22-21 04:01AM |
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney diseaseGlobeNewswire Inc. |